FDA warns companies marketing dietary supplements that contain methylsynephrine.
- As previously covered on this blog, FDA has the authority to take enforcement action against unlawfully marketed and/or dangerous dietary ingredients
Legal and Regulatory updates for the food and supplement industry
FDA warns companies marketing dietary supplements that contain methylsynephrine.
FDA announces seizure of dietary supplements containing kratom.
Leading trade association plans to develop voluntary dietary supplement registry.
DMAA still available despite FDA’s “ban.”
Researchers report effectiveness of FDA ban on ephedra.
FDA takes enforcement action against BMPEA.